PRIVIA HEALTH GROUP INC (PRVA) Stock Fundamental Analysis

NASDAQ:PRVA • US74276R1023

22.39 USD
+0.89 (+4.14%)
At close: Feb 13, 2026
22.39 USD
0 (0%)
After Hours: 2/13/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, PRVA scores 4 out of 10 in our fundamental rating. PRVA was compared to 102 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for PRVA as it has an excellent financial health rating, but there are worries on the profitability. PRVA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • PRVA had positive earnings in the past year.
  • In the past year PRVA had a positive cash flow from operations.
  • In multiple years PRVA reported negative net income over the last 5 years.
  • Each year in the past 5 years PRVA had a positive operating cash flow.
PRVA Yearly Net Income VS EBIT VS OCF VS FCFPRVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.34%, PRVA is in line with its industry, outperforming 51.96% of the companies in the same industry.
  • PRVA's Return On Equity of 2.56% is in line compared to the rest of the industry. PRVA outperforms 55.88% of its industry peers.
  • PRVA has a Return On Invested Capital (2.45%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.34%
ROE 2.56%
ROIC 2.45%
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
PRVA Yearly ROA, ROE, ROICPRVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • PRVA has a Profit Margin (0.89%) which is in line with its industry peers.
  • PRVA's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 1.38%, PRVA is in line with its industry, outperforming 44.12% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PRVA has declined.
  • PRVA has a worse Gross Margin (10.17%) than 74.51% of its industry peers.
  • PRVA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.38%
PM (TTM) 0.89%
GM 10.17%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
PRVA Yearly Profit, Operating, Gross MarginsPRVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRVA is destroying value.
  • The number of shares outstanding for PRVA has been increased compared to 1 year ago.
  • PRVA has more shares outstanding than it did 5 years ago.
  • PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PRVA Yearly Shares OutstandingPRVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
PRVA Yearly Total Debt VS Total AssetsPRVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 4.33 indicates that PRVA is not in any danger for bankruptcy at the moment.
  • PRVA's Altman-Z score of 4.33 is fine compared to the rest of the industry. PRVA outperforms 77.45% of its industry peers.
  • PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.33
ROIC/WACC0.28
WACC8.68%
PRVA Yearly LT Debt VS Equity VS FCFPRVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
  • PRVA has a better Current ratio (1.67) than 63.73% of its industry peers.
  • A Quick Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
  • PRVA's Quick ratio of 1.67 is fine compared to the rest of the industry. PRVA outperforms 68.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.67
PRVA Yearly Current Assets VS Current LiabilitesPRVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.00% over the past year.
  • PRVA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.43% yearly.
  • The Revenue has grown by 19.01% in the past year. This is quite good.
  • PRVA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.17% yearly.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 59.93% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, PRVA will show a small growth in Revenue. The Revenue will grow by 2.73% on average per year.
EPS Next Y22%
EPS Next 2Y71.06%
EPS Next 3Y59.93%
EPS Next 5YN/A
Revenue Next Year-27.71%
Revenue Next 2Y-9.42%
Revenue Next 3Y-3.6%
Revenue Next 5Y2.73%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PRVA Yearly Revenue VS EstimatesPRVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PRVA Yearly EPS VS EstimatesPRVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 172.23, PRVA can be considered very expensive at the moment.
  • PRVA's Price/Earnings is on the same level as the industry average.
  • PRVA is valuated expensively when we compare the Price/Earnings ratio to 26.68, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 69.56, PRVA can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PRVA is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, PRVA is valued quite expensively.
Industry RankSector Rank
PE 172.23
Fwd PE 69.56
PRVA Price Earnings VS Forward Price EarningsPRVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PRVA is valued a bit more expensive than the industry average as 62.75% of the companies are valued more cheaply.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as PRVA.
Industry RankSector Rank
P/FCF 24.88
EV/EBITDA 62.02
PRVA Per share dataPRVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRVA does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as PRVA's earnings are expected to grow with 59.93% in the coming years.
PEG (NY)7.83
PEG (5Y)23.17
EPS Next 2Y71.06%
EPS Next 3Y59.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PRVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PRIVIA HEALTH GROUP INC

NASDAQ:PRVA (2/13/2026, 8:00:00 PM)

After market: 22.39 0 (0%)

22.39

+0.89 (+4.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners98.68%
Inst Owner Change-0.92%
Ins Owners1.85%
Ins Owner Change0%
Market Cap2.75B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.29
Price Target32.15 (43.59%)
Short Float %2.23%
Short Ratio3.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)-0.08%
PT rev (3m)-0.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-39.01%
EPS NY rev (1m)0%
EPS NY rev (3m)-20.77%
Revenue NQ rev (1m)-4.09%
Revenue NQ rev (3m)-29.23%
Revenue NY rev (1m)-39.88%
Revenue NY rev (3m)-37.44%
Valuation
Industry RankSector Rank
PE 172.23
Fwd PE 69.56
P/S 1.35
P/FCF 24.88
P/OCF 24.88
P/B 3.88
P/tB 7.46
EV/EBITDA 62.02
EPS(TTM)0.13
EY0.58%
EPS(NY)0.32
Fwd EY1.44%
FCF(TTM)0.9
FCFY4.02%
OCF(TTM)0.9
OCFY4.02%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)7.83
PEG (5Y)23.17
Graham Number4.11
Profitability
Industry RankSector Rank
ROA 1.34%
ROE 2.56%
ROCE 3.67%
ROIC 2.45%
ROICexc 5.77%
ROICexgc N/A
OM 1.38%
PM (TTM) 0.89%
GM 10.17%
FCFM 5.42%
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 112.37
Cash Conversion 296.89%
Profit Quality 609.36%
Current Ratio 1.67
Quick Ratio 1.67
Altman-Z 4.33
F-Score7
WACC8.68%
ROIC/WACC0.28
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y22%
EPS Next 2Y71.06%
EPS Next 3Y59.93%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year-27.71%
Revenue Next 2Y-9.42%
Revenue Next 3Y-3.6%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.42%
EBIT Next 3Y111.21%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%

PRIVIA HEALTH GROUP INC / PRVA FAQ

What is the fundamental rating for PRVA stock?

ChartMill assigns a fundamental rating of 4 / 10 to PRVA.


Can you provide the valuation status for PRIVIA HEALTH GROUP INC?

ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.


Can you provide the profitability details for PRIVIA HEALTH GROUP INC?

PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for PRVA stock?

The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 172.23 and the Price/Book (PB) ratio is 3.88.


Can you provide the financial health for PRVA stock?

The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.